Curing with Sound

In this episode of Curing with Sound, we speak with Jim Rorie, a licensed private investigator from North Carolina whose career and daily life were profoundly affected by chronic low back pain following a multi-vehicle collision. After months of physical therapy and painful nerve block injections, Jim became one of the first patients in the United States to be commercially treated with noninvasive focused ultrasound for his back pain. 

He shares what led him to the procedure, what the treatment experience was like, and how it has transformed his pain, his work, and his quality of life.

Discussion highlights:

First-of-its-Kind Device Receives FDA Clearance: In November 2025, the FUSMobile Neurolyser XR system received De Novo clearance from the US Food and Drug Administration (FDA) for the treatment of chronic low back pain. The device, which uses focused ultrasound to ablate sensory nerves in the spinal facet joints, is also approved in Europe, Canada, and the UK.

Renewed Hope and Quality of Life: Jim reflects on the difference focused ultrasound has made in his recovery, allowing him to return to his career as a private investigator and regain activities that chronic pain had previously limited.

EPISODE TRANSCRIPT

----------------------------

QUESTIONS?
Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances. 

Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation. 

FUSF SOCIAL MEDIA

LinkedIn

X

Facebook

Instagram

TikTok

YouTube

FUSF WEBSITE
https://www.fusfoundation.org

FOCUSED ULTRASOUND TREATMENT SITES
https://www.fusfoundation.org/the-technology/treatment-sites/

SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/

READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/

DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

In this episode of Curing with Sound, we speak with Matt Myers, PhD, a research physicist and founder of Puente Translational Sciences. Dr. Myers spent more than 30 years at the U.S. Food and Drug Administration (FDA), where he helped develop tools to evaluate emerging devices and applications, including focused ultrasound. Drawing on decades of experience, Dr. Myers offers an insider's perspective on the FDA's role in advancing medical innovation and explains how researchers and device developers can work more effectively with regulators to accelerate patient access to new therapies.

He discusses his early involvement with the first focused ultrasound submission for uterine fibroids, his important work during the COVID-19 pandemic, and his current efforts to help researchers and manufacturers accelerate the path to market for therapeutic ultrasound devices.

Discussion highlights:

Working with the FDA: How the FDA collaborates with researchers and manufacturers to improve devices, streamline regulatory pathways, and help bring safe and effective technologies to patients.

The Evolving Field of Neuromodulation: Why focused ultrasound neuromodulation is generating growing regulatory interest, and how standardized reporting will strengthen future research and clinical translation.

Preparing the Next Generation: Dr. Myers' advice for early-career researchers on developing the technical skills and interdisciplinary expertise needed to succeed in the rapidly evolving field of therapeutic ultrasound.

EPISODE TRANSCRIPT

----------------------------

QUESTIONS?
Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances. 

Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation. 

FUSF SOCIAL MEDIA

LinkedIn

X

Facebook

Instagram

TikTok

YouTube

FUSF WEBSITE
https://www.fusfoundation.org

FOCUSED ULTRASOUND TREATMENT SITES
https://www.fusfoundation.org/the-technology/treatment-sites/

SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/

READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/

DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

Focused ultrasound is rapidly expanding the boundaries of what is possible in functional neurosurgery. From movement disorders to epilepsy, researchers are exploring how this noninvasive technology can precisely target and treat an expanding range of neurological conditions.

In this episode of Curing with Sound, Vibhor Krishna, MD, Associate Professor and Vice Chair of Inpatient Operations in the Department of Neurosurgery at the University of North Carolina, discusses the latest advances in focused ultrasound for neurological disorders. Dr. Krishna shares moving patient stories, reviews newly approved bilateral treatment for Parkinson’s disease, and shares encouraging early findings from a Phase I clinical trial for treatment-resistant epilepsy.

The conversation also explores the broader therapeutic landscape for epilepsy and the opportunities ahead as focused ultrasound research continues to advance.

Discussion highlights:

Incisionless Tremor Relief: Discover how focused ultrasound offers a life-changing, noninvasive option for patients with essential tremor who wish to avoid invasive surgery and implanted hardware.

Bilateral Parkinson's Treatment: Learn about the recent FDA approval for ablating the palatothalamic tract (PTT) bilaterally, a staged approach that addresses fluctuating symptoms like stiffness and slowness while potentially reducing medication dependence.

Pioneering Epilepsy Trials: Hear promising early results of a Phase I clinical trial using focused ultrasound to reduce seizure frequency in patients with treatment-resistant epilepsy.

EPISODE TRANSCRIPT

----------------------------

QUESTIONS?
Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances. 

Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation. 

FUSF SOCIAL MEDIA

LinkedIn

X

Facebook

Instagram

TikTok

YouTube

FUSF WEBSITE
https://www.fusfoundation.org

FOCUSED ULTRASOUND TREATMENT SITES
https://www.fusfoundation.org/the-technology/treatment-sites/

SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/

READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/

DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

In this episode of Curing with Sound, we speak with Ashish Ranjan, PhD, a professor of radiation oncology and director of the Veterinary Research and Oncology Clinic at the University of Texas Southwestern. Dr. Ranjan discusses how emerging focused ultrasound applications, including histotripsy and sonodynamic therapy, are being used to treat solid tumors in companion animals. 

He explains how veterinary oncology research contributes to advances in human medicine, shares findings from ongoing clinical studies, and explores the potential of combining focused ultrasound with immunotherapy, radiation therapy, and other cancer treatments. Learn how comparative oncology is helping shape the future of personalized, noninvasive cancer care for both veterinary and human patients. 

Discussion highlights:

The One Health Approach: Learn how studying naturally occurring diseases in companion animals can accelerate therapeutic development, providing a powerful bridge between veterinary and human medicine and helping researchers evaluate new treatments more efficiently.

Veterinary Research and Oncology Clinic (VROC): Discover how VROC combines advanced clinical care with cutting-edge research to offer dogs and cats access to innovative cancer treatments. The clinic evaluates emerging technologies, such as focused ultrasound, and other novel therapies, and maintains a strong focus on patient comfort, quality of life, and individualized care. 

EPISODE TRANSCRIPT

----------------------------

QUESTIONS?
Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances. 

Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation. 

FUSF SOCIAL MEDIA

LinkedIn

X

Facebook

Instagram

TikTok

YouTube

FUSF WEBSITE
https://www.fusfoundation.org

FOCUSED ULTRASOUND TREATMENT SITES
https://www.fusfoundation.org/the-technology/treatment-sites/

SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/

READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/

DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

Targeted drug delivery to the brain has long been hindered by the blood-brain barrier, a protective layer that prevents many therapeutic agents from reaching their intended targets. For patients with serious neurological disorders, this challenge can significantly reduce access to potentially effective treatments and limit therapeutic outcomes. 

In this episode of Curing with Sound, we speak with Sasha Klibanov, PhD, Associate Professor in the Division of Cardiovascular Medicine at the University of Virginia and a pioneering researcher in microbubble technology. Dr. Klibanov discusses the evolution of microbubbles from imaging contrast agents to sophisticated tools for drug delivery. He also explains how focused ultrasound, combined with microbubbles, can safely and temporarily open the blood-brain barrier, creating new opportunities for precision therapies and advancing the potential of immunotherapy. 

Discussion highlights:

Microbubble Technology Explained: Explore how microbubbles evolved from diagnostic imaging tools into powerful agents for precise drug delivery when combined with focused ultrasound.

Advancing Immunotherapy: Learn about Dr. Klibanov's collaborative research on using size-sorted microbubbles to optimize the opening of the blood-brain barrier, potentially revolutionizing how we treat complex diseases by enabling targeted immune responses.

EPISODE TRANSCRIPT

----------------------------

QUESTIONS?
Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances. 

Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation. 

FUSF SOCIAL MEDIA

LinkedIn

X

Facebook

Instagram

TikTok

YouTube

FUSF WEBSITE
https://www.fusfoundation.org

FOCUSED ULTRASOUND TREATMENT SITES
https://www.fusfoundation.org/the-technology/treatment-sites/

SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/

READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/

DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/